The fund should come out of a review of the Development Bank of Wales’ funding remit
One of the most interesting economic announcements from the Welsh Government in recent weeks was not a new strategy or another consultation exercise, but a small loan scheme for farmers.
On the face of it, the Sustainable Agriculture Loan Scheme is a modest £5m pilot, delivered through the Development Bank of Wales, offering fixed-rate loans to farms seeking to invest in renewable energy, energy efficiency, storage, waste and nutrient management, equipment, processing and infrastructure.
It is long overdue, as Welsh farming is undergoing a difficult transition and many farms will need capital to modernise, reduce costs and adapt to the demands placed on them. A long-term loan at an affordable rate is more disciplined than simply handing out grants, and if an investment saves money, raises output or strengthens the business, finance should be repaid over time.
But the more important question is why this approach should apply only to agricultural businesses? If a farm can access patient, affordable financing to invest in solar panels, new equipment, or improved processing capacity, why should a manufacturer, food producer, hotel, engineering firm, or logistics business not be able to do the same?
The underlying economic problem is not unique to agriculture, as too many Welsh firms lack the capital, confidence, or incentive to invest in the technology, equipment, and systems that would make them more productive. That matters because productivity is now supposed to be the North Star of Welsh economic policy, which is not surprising given that GVA per hour worked in Wales was just 84.9 per cent of the UK average in 2023, the lowest of the twelve UK nations and English regions.
Yet if productivity is the objective, the machinery of economic development has to change, and all the institutions of Welsh economic policy need to be directed squarely at the problem and that must start with the Development Bank of Wales,
However, there is a major problem here, as its annual business loan interest rates currently range from 6.25% to 13%. As the bank’s senior management has argued many times, those rates reflect risk, security, and each applicant’s financial position, and that is how commercial lending works.
But compare that with the new farm scheme, which offers a fixed rate of 3%, loans from £25,000 to £1m, repayment terms of up to 15 years, and a six-month repayment holiday. That is not a small difference but a completely different proposition, and a Welsh business borrowing at the development bank’s average rate of 8.56% over five years faces a very different investment calculation from that of a farm borrowing under this scheme.
Certainly, if the Welsh Government believes that patient capital with lower interest rates over an extended repayment period can help farms invest to become more productive, resilient, and sustainable, then why is the same principle not being applied to investment across the wider Welsh economy, as some of us have been proposing for years?
Given this, should the development bank now make productivity-enhancing investment its primary strategic purpose and reorganise the bank’s public mission around a clearer test: i.e., will this investment raise output, reduce costs, improve margins, increase wages, expand capacity, strengthen exports, or reduce carbon intensity? If the answer is yes, then that business should be eligible for patient, affordable finance
So why not introduce a Welsh productivity investment loan as the development bank’s flagship product?
It could support smaller firms with microloans for digital systems, software, energy efficiency, equipment and process improvements. It could back established SMEs with larger loans for machinery, automation, robotics, storage, production systems, AI adoption and low-carbon technology. It could fund long-term strategic projects in manufacturing, food and drink, tourism, life sciences, engineering and advanced services where the investment case is clear.
The key is that the test should be the investment, not the sector, and a farm investing in new storage capacity or a food manufacturer investing in refrigeration and automation may be solving different operational problems, but economically they are both trying to do the same thing, which is to produce more value from the same or fewer inputs.
This is where public finance can make a real difference, as commercial lenders are often cautious about long-term productivity investments, especially for smaller firms without strong asset backing. Many businesses know they need to invest but hesitate because payback periods are uncertain, interest rates are high, or day-to-day pressures consume management attention. Indeed, that was one of the primary reasons for creating the Development Bank of Wales 12 years ago.
Of course, this should not become cheap debt for weak firms with no future as Wales does not need a subsidised survival fund for businesses that are not prepared to change. This would also change how we measure success, as too often, economic development in Wales has been judged by how much money is lent, how many businesses are supported, or how many jobs are claimed and not by productivity outcomes such as turnover per employee, margin improvement, wage growth, energy efficiency, export growth, capacity increases, and private investment leveraged.
The farm loan scheme should therefore be seen not as an exception, but as a pilot for the rest of the Welsh economy. If long-term, affordable finance can help farms invest to become more resilient and productive, then the same principle should apply across the Welsh business base.
The new Welsh Government has promised to review the activities of the development bank so what better time to shift its strategic focus from general business finance to a national productivity mission?
Because if Wales is serious about closing the gap with the rest of the UK, then the question every publicly backed business loan should ask is simple: will this make a Welsh firm more productive and if the answer is yes, then give those firms the affordable patient capital to make it happen.



You must be logged in to post a comment Login